Title:
|
MONOCLONAL ANTIBODY THERAPY - COMMISSIONER RICH
ACTION: (T-3:54 PM) Commissioner Rich noted removal of monoclonal antibody treatment drugs for the treatment of COVID-19 from the market by the FDA, referencing Regeneron and Eli Lilly studies confirming loss of effectiveness. (Refer to minutes for full discussion.)
|